Company / Operating Income
Altimmune, Inc. Operating Income History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$94.5M
FY2025
5-year range
-$96.9M / -$54.8M
FY2021-FY2025
Trend
+1.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income has fluctuated over the past 10 years, ranging from -$97M in FY2022 to -$11M in FY2017.
Based on SEC 10-K filings.
-$94M in FY2025.
Declined from -$88M to -$94M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income increased 1.5% year-over-year.
- Peak operating income was recorded in FY2017.
- Lowest operating income in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$94.5M | +1.5% |
| FY2024 | -$95.9M | -9.3% |
| FY2023 | -$87.7M | +9.5% |
| FY2022 | -$96.9M | -76.9% |
| FY2021 | -$54.8M | -155.3% |
| FY2020 | -$21.5M | +49.9% |
| FY2019 | -$42.8M | +17.7% |
| FY2018 | -$52.0M | -369.2% |
| FY2017 | -$11.1M | +52.9% |
| FY2011 | -$23.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026